Buell Jennifer Insider Trades

Insider Trading History

Track insider trading activity for Buell Jennifer. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Agenus
Agenus AGEN
See Remarks
Holding Value $1.02M 300,000 shares
Last Trade
Apr 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 305,000 shares
$3.90
$3.40
MiNK Therapeutics
MiNK Therapeutics INKT
Chief Executive Officer
Holding Value $867k 67,966 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$906k 81,474 shares
$11.12
$12.75
MiNK Therapeutics
MiNK Therapeutics INKT
Chief Executive Officer
Holding Value $739k 57,942 shares
Last Trade
Jan 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$111k 10,024 shares
$11.12
$12.75
MiNK Therapeutics
MiNK Therapeutics INKT
Chief Executive Officer
Holding Value $465k 36,492 shares
Last Trade
Sep 09, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$82.2k 5,351 shares
$15.36
$12.75
MiNK Therapeutics
MiNK Therapeutics INKT
Chief Executive Officer
Holding Value $638k 50,000 shares
Last Trade
Sep 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 68,229 shares
$15.36
$12.75
Agenus
Agenus AGEN
Director
Holding Value $67k 19,738 shares
Last Trade
May 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.81k 581 shares
$3.11
$3.40
Agenus
Agenus AGEN
Director
Holding Value $65k 19,157 shares
Last Trade
Apr 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.81k 869 shares
$2.08
$3.40
Agenus
Agenus AGEN
Director
Holding Value $62.1k 18,288 shares
Last Trade
Apr 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.81k 1,159 shares
$1.56
$3.40
Agenus
Agenus AGEN
Director
Holding Value $58.2k 17,129 shares
Last Trade
Mar 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.81k 1,123 shares
$1.61
$3.40
Agenus
Agenus AGEN
Director
Holding Value $53.1k 15,646 shares
Last Trade
Mar 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$961 409 shares
$2.35
$3.40
Agenus
Agenus AGEN
Director
Holding Value $52k 15,318 shares
Last Trade
Feb 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.08k 626 shares
$3.32
$3.40
Agenus
Agenus AGEN
Director
Holding Value $51.7k 15,237 shares
Last Trade
Feb 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.81k 545 shares
$3.32
$3.40
Agenus
Agenus AGEN
Director
Holding Value $49.9k 14,692 shares
Last Trade
Feb 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.81k 516 shares
$3.50
$3.40
Agenus
Agenus AGEN
Director
Holding Value $49k 14,446 shares
Last Trade
Jan 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.77k 776 shares
$3.57
$3.40
Agenus
Agenus AGEN
Director
Holding Value $48.1k 14,176 shares
Last Trade
Jan 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$964 270 shares
$3.57
$3.40
Agenus
Agenus AGEN
Chairman Executive Council
Holding Value $1.02M 300,000 shares
Last Trade
Nov 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$831k 300,000 shares
$2.77
$3.40
Agenus
Agenus AGEN
Chairman Executive Council
Holding Value $46.4k 13,670 shares
Last Trade
Jun 11, 2024 Sale
$629k 37,500 shares
$16.78
$3.40
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Director
Holding Value $39.8k 75,000 shares
Last Trade
Mar 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.83M 75,000 shares
$24.36
$0.53
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Director
Holding Value $1.13k 75,000 shares
Last Trade
Mar 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.03k 75,000 shares
$0.03
$0.02
MiNK Therapeutics
MiNK Therapeutics INKT
Chief Executive Officer
Holding Value $8.43M 660,919 shares
Last Trade
Jan 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.1M 1,160,919 shares
$8.70
$12.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up